This inventor holds 8 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignee: Oryzon Genomics S.a.. Active years: 2015-2019.
Company Filing History:
Years Active: 2015-2019
Title: Inventor Spotlight: Nuria Valls Vidal
Introduction
Nuria Valls Vidal is an accomplished inventor based in Barcelona, Spain, with a remarkable portfolio of eight patents. Her work primarily focuses on innovative compounds that have significant implications in the medical field, particularly in the treatment of various diseases.
Latest Patents
Among her latest contributions to science are several groundbreaking patents regarding (hetero)aryl cyclopropylamine compounds, which serve as LSD1 inhibitors. These inventions detail the compounds of formula I and their potential use in therapies aimed at treating or preventing conditions such as cancer, neurological diseases, and viral infections. The patented compounds signify a promising advancement in therapeutic options for various critical health issues.
Career Highlights
Nuria Valls Vidal currently works at Oryzon Genomics S.A., a company renowned for its research and development in innovative genomic solutions. Her role at the company allows her to contribute significantly to the field of genomics, enhancing our understanding and treatment of complex diseases through innovative therapies.
Collaborations
Throughout her career, Nuria has collaborated with notable coworkers such as Matthew Colin Thor Fyfe and Alberto Ortega Muñoz. These collaborations bring together diverse expertise, fostering innovative approaches to drug discovery and development.
Conclusion
Nuria Valls Vidal stands out as a pivotal figure in the field of innovation, particularly through her patented inventions that hold the promise of revolutionizing treatments for serious health conditions. Her dedication to advancing medical science is reflected in her work at Oryzon Genomics and her collaborative efforts with her peers.